Central nervous system drugs
Central nervous system drugs has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Feb 12, 2026: “Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study”.
1 paper studies it2 findingsUpdated
“DDIs with CNS drugs were associated with stroke (1.19 [1.09-1.29]) and falls (1.32 [1.27-1.39]).”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: European Commission and 1 more
- Humans1
What is Central nervous system drugs linked with?
2Studies link Central nervous system drugs with 2 measures, most often falls (1 study) and stroke (1).
Falls
upin humans1HR 1.32
1 study
Falls
upin humans1HR 1.32
Central nervous system drugs are associated with falls in humans (HR 1.32, 95% CI [1.27-1.39]).
“DDIs with CNS drugs were associated with stroke (1.19 [1.09-1.29]) and falls (1.32 [1.27-1.39]).”
Humansatrial fibrillation and multimorbidity2-year follow-upn = 192,716
Cardiovascular drugs and therapy
Stroke
upin humans1HR 1.19
1 study
Stroke
upin humans1HR 1.19
Central nervous system drugs are associated with stroke in humans (HR 1.19, 95% CI [1.09-1.29]).
“DDIs with CNS drugs were associated with stroke (1.19 [1.09-1.29]) and falls (1.32 [1.27-1.39]).”
Humansatrial fibrillation and multimorbidity2-year follow-upn = 192,716
Cardiovascular drugs and therapy